Protective efficacy of BCG vaccine against leprosy in southern Malaŵi
- 1 August 1993
- journal article
- research article
- Published by Cambridge University Press (CUP) in Epidemiology and Infection
- Vol. 111 (1) , 21-25
- https://doi.org/10.1017/s0950268800056636
Abstract
Summary This paper describes a matched case-control study to determine the efficacy of BCG vaccine in preventing the occurrence of leprosy in southern Malaŵi, a previously unstudied area. The BCG immunization rate amongst 145 individuals with leprosy was 44.8%, compared to 62.5% in 290 matched controls. The protective efficacy of BCG vaccine against leprosy in this region was estimated to be 63.6%; smallpox immunization had no effect. These findings support the view that BCG vaccine should be considered as a control measure in areas where leprosy is endemic.Keywords
This publication has 17 references indexed in Scilit:
- Efficacy of BCG vaccine against leprosy and tuberculosis in northern MalawiThe Lancet, 1992
- Mycobacterial diseasesThe Lancet, 1990
- PROTECTIVE EFFICACY OF BCG AGAINST LEPROSY IN NORTHERN MALAWIThe Lancet, 1986
- Assessment of the Protective Efficacy of Vaccines against Common Diseases Using Case-Control and Cohort StudiesInternational Journal of Epidemiology, 1984
- Retrospective assessment of the effectiveness of BCG vaccination against tuberculosis using the case-control methodTubercle, 1982
- BCG vaccination of children against leprosy in Uganda: final resultsEpidemiology and Infection, 1981
- BCG and vole bacillus vaccines in the prevention of tuberculosis in adolescence and early adult life.BMJ, 1977
- Evaluation of BCG vaccination among Puerto Rican children.American Journal of Public Health, 1974
- [Observation concerning the protective effect of BCG vaccination in the rural population of South India: report number 4].1973
- Classification of leprosy according to immunity. A five-group system.1966